BriaCell Therapeutics Corp. SEC filings BCTX
BriaCell Therapeutics Corp. has 324 filings in SEC EDGAR's recent list, going back to Jun 20, 2014. Its latest annual report, Form 10-K, was filed on Oct 28, 2026 for the period ended Jul 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 9, 2026, covering the quarter ended Apr 30, 2026. The most recent current report (Form 8-K) was filed on Jun 26, 2026 (regulation fd disclosure). The company's fiscal year ends on July 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 23, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 10, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 22, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 1, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 12, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 10, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 5, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Sep 16, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 24, 2024 | — |
| 4 | Insider transaction | May 20, 2024 | May 14, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| 4 | Insider transaction | Dec 28, 2022 | Dec 28, 2022 |
| 4 | Insider transaction | Dec 28, 2022 | Dec 23, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 20, 2022 |
| 3 | Initial insider ownership | Aug 11, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 2, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| 3 | Initial insider ownership | Aug 1, 2022 | Aug 1, 2022 |
| SC 13G | Ownership over 5% (passive) | Aug 1, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Apr 25, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 4, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 20, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 4, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 20, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Sep 13, 2021 | — |
| SC 13D | Ownership over 5% (active) | Sep 7, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Aug 17, 2021 | — |
| SC 13D | Ownership over 5% (active) | Aug 9, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 4, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Jun 28, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Jun 14, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Mar 8, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Mar 5, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Mar 3, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Mar 2, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 26, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 26, 2021 | — |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BCTX (Nasdaq), BCTXL (Nasdaq), BCTXZ (Nasdaq)
- Fiscal year ends
- July 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- West Vancouver, British Columbia, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1610820
- Former names
- Ansell Capital Corp. (until Jun 20, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.